- About Us
- Business Domains
- Muse Cells and Regenerative Medicine
- Contact Us
Life Science Institute, Inc. (LSII) registers and discloses information about clinical trials that are being conducted or have been conducted by LSII and investigator-initiated clinical trials supported by LSII on publicly accessible clinical trial registries, such as the Clinical Trial Information Database (JapicCTI) website operated by the Japan Pharmaceutical Information Center or clinical trial implementation plan/research summary disclosure system (jRCT). Information about some studies will be also available on the ClinicalTrials.gov website managed by the US National Library of Medicine.
The information on this web page is not intended to promote, advertise, or recommend off-label or unapproved use of any product.
Exploratory study of CL2020 in ST-elevation acute myocardial infarction
A randomized, double-blind, placebo-controlled clinical study of CL2020 in ischemic stroke patients
A clinical study of CL2020 in patients with epidermolysis bullosa
A clinical study of CL2020 in patients with spinal cord injury
A confirmatory study of CL2020 in patients with ST-elevation myocardial infarction
An exploratory clinical trial of CL2020 in patients with amyotrophic lateral sclerosis
Clinical study of CL2020 in patients with acute respiratory distress syndrome associated with SARS-CoV-2 infection (Clinical study of CL2020 in patients with acute respiratory distress syndrome associated with SARS-CoV-2 infection)